Parametrica Management LTD Pfizer Inc Transaction History

Parametrica Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $2.52 Million - $3.29 Million	60,385 Added 424.83%	74,599 $3.82 Million
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $3.88 Million - $4.73 Million	-88,592 Reduced 86.17%	14,214 $623,000
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $1.5 Million - $1.78 Million	-32,309 Reduced 23.91%	102,806 $5.4 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $6.18 Million - $7.66 Million	135,115 New	135,115 $7 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $303,184 - $341,931	-9,053 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $703,773 - $894,909	-21,027 Reduced 69.9%	9,053 $333,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $955,040 - $1.12 Million	30,080 New	30,080 $1.1 Million
Q1 2018 Apr 24, 2018	SELL	$31.91 - $37.02 $221,870 - $257,400	-6,953 Closed	0 $0
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $159,714 - $169,462	-4,802 Reduced 40.85%	6,953 $252,000
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $364,405 - $401,433	11,755	11,755 $420,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.